FGF21 and its Relationship with Inflammatory and Metabolic Parameters in HIV Patients after Antiretroviral Treatment.

Current HIV Research
Alan Joel Ruiz-PadillaMónica Del Carmen Preciado-Puga

Abstract

Fibroblast Growth Factor 21 (FGF21) serum levels are associated with insulin resistance and metabolic syndrome in HIV patients. To quantify FGF21 levels in HIV patients using antiretroviral therapy (ART) and to analyze a possible association between serum FGF21 levels and lipid profile, levels of proinflammatory cytokines, and atherogenic risk factors. Twenty patients with HIV infection, who received ART in a scheme consisting of Tenofovir/Emtricitabine+Lopinavir/Ritonavir, were enrolled in this study. The serum levels of FGF21, inflammatory parameters (IL-6 and IL-1β), glucose, cholesterol, triglycerides, and insulin were determined at baseline and after 36 weeks of treatment. The homeostatic model assessment for insulin resistance (HOMA-IR) and the atherogenic risk factor were also calculated. After 36 weeks, serum FGF21 levels decreased significantly (p=0.011), whereas IL-6 levels (r=0.821, p=0.0001) and the CD4+ T cell count (r=0.446, p=0.048), showed a positive correlation with the decrease in FGF21 levels. There was an increase in total cholesterol (r=-0.483, p=0.031), LDL (r=-0.496, p=0.026), VLDL (r=-0.320, p=0.045), and the atherogenic index factor (r=-0.539, p=0.014), these values showed a negative correlation with FG...Continue Reading

References

May 30, 2001·Bioorganic & Medicinal Chemistry Letters·H L ShamD W Norbeck
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark S Sulkowski
Mar 31, 2004·The Lancet Infectious Diseases·Katleen de Gaetano DonatiRoberto Cauda
Jan 7, 2005·The New England Journal of Medicine·Steven Grinspoon, Andrew Carr
May 20, 2005·The Journal of Clinical Investigation·Alexei KharitonenkovArmen B Shanafelt
Aug 29, 2007·Clinics in Liver Disease·Mamta K Jain
Sep 12, 2008·AIDS Patient Care and STDs·Nancy F Crum-CianfloneMary Bavaro
May 11, 2010·Gastroenterology·Jody DushayEleftheria Maratos-Flier
Jul 20, 2010·JAMA : the Journal of the American Medical Association·Melanie A ThompsonUNKNOWN International AIDS Society-USA
Oct 7, 2011·Endocrine Research·Xingbo ChengHuaying Fan
Jan 12, 2012·The Biochemical Journal·Ana Luísa De Sousa-CoelhoDiego Haro
Aug 31, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Xiao DingKendall A Marcus
Nov 7, 2012·The Journal of Endocrinology·Susan KralischMathias Fasshauer
Nov 29, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·José M Gallego-EscuredoFrancesc Villarroya
Jun 15, 2013·Endocrinology·João Paulo G CamporezGerald I Shulman
Jul 28, 2013·Advances in Immunology·Michael M LedermanPeter W Hunt
Oct 26, 2013·The Lancet Infectious Diseases·Jordan E Lake, Judith S Currier
Apr 8, 2014·The Journal of Medical Investigation : JMI·Qing-Ri JinSumihare Noji
Aug 26, 2014·Infectious Disease Clinics of North America·Alice K Pau, Jomy M George
Dec 15, 2015·Annual Review of Physiology·Ffolliott Martin Fisher, Eleftheria Maratos-Flier
Mar 10, 2016·Current HIV Research·Suzie Thenin-Houssier, Susana T Valente
Dec 14, 2016·Therapeutics and Clinical Risk Management·Elizabeth GoriZvenyika Alfred Gomo
Mar 25, 2017·Current Hypertension Reports·Zhe HuangBernard M Y Cheung
May 20, 2017·Metabolism: Clinical and Experimental·José M Gallego-EscuredoMarta Giralt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.